Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heel belgium sa-nv - argentum nitricum 1 mg; atropa bella-donna 1 mg; ceanothus americanus 1 mg; hydrastis canadensis 1 mg; psychotria ipecacuanha 1 mg; kalium bichromicum 1 mg; lachesis 1 mg; mandragora e radice siccata l., dried roots 1 mg; mucosa coli suis 1 mg; mucosa ductus choledochi suis 1 mg; mucosa ilei suis 1 mg; mucosa jejuni suis 1 mg; mucosa nasalis suis 1 mg; mucosa oculi suis 1 mg; mucosa oesophagi suis 1 mg; mucosa oris suis 1 mg; mucosa pulmonis suis 1 mg; mucosa pylori suis 1 mg; mucosa rectalis suis 1 mg; mucosa vesicae felleae suis 1 mg; mucosa vesicae urinariae suis 1 mg; strychnos nux-vomica 1 mg; oxalis acetosella 1 mg; pancreas suis 1 mg; phosphorus 1 mg; pulsatilla pratensis 1 mg; sulfur. 1 mg; veratrum album 1 mg; marsdenia cundurango rchb f., dried cortex from stems and branches 1 mg; anacardium orientale l., dried fruit 1 mg; kreosotum 1 mg; momordica balsamina l., fresh fruits 1 mg; mucosa duodeni suis 1 mg; ventriculus suis 1 mg - tablet

United States - English - NLM (National Library of Medicine)

20lighter, llc. - adenosine triphosphate (unii: 8l70q75fxe) (adenosine triphosphate - unii:8l70q75fxe), lard (unii: si6o3iw77z) (lard - unii:si6o3iw77z), sus scrofa cerebrum (unii: 4gb5dqr532) (sus scrofa cerebrum - unii:4gb5dqr532), coenzyme a (unii: saa04e81ux) (coenzyme a - unii:saa04e81ux), sus scrofa colon (unii: 94j255a0uc) (sus scrofa colon - unii:94j255a0uc), sus scrofa duodenum (unii: p6j2sft80o) (sus scrofa duodenum - unii:p6j2sft80o), bos taurus bile (unii: et3651zlou) (bos taurus bile - unii:et3651zlou), f - uses: for the temporary relief of symptoms of food cravings, including: constant appetite, increased or insatiable hunger.*

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2q1 claria mri quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies the claria mri quad system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2d1 claria mri dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the claria mri system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtmb2d1 amplia mri dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the amplia mri system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2d4 claria mri dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the claria mri system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtmb2d4 amplia mri dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the amplia mri system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2qq claria mri quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the claria mri quad system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtmb2qq amplia mri quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the amplia mri quad system is indicated for use in patients who are at high risk of sudden death due to ventricular tachyarrhythmias and who have heart failure with ventricular dyssynchrony. the device is intended to provide atrial and/or ventricular antitachycardia pacing, cardioversion, and defibrillation for automated treatment of atrial and/or life-threatening ventricular tachyarrhythmias.